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Abstract
Inflammasomes are cytosolic caspase-1 activation complexes that sense intrinsic and extrinsic 
danger signals to trigger inflammatory responses and pyroptotic cell death. Homotypic interactions 
by Pyrin domains (PYD) and caspase recruitment domains (CARD) in inflammasome component 
proteins mediate oligomerization into filamentous assemblies. Several cytosolic proteins 
consisting of only the interaction domains exert inhibitory effects on inflammasome assembly. In 
this study, we determined the structure of human caspase-1CARD filament by cryo-electron 
microscopy and investigated the biophysical properties of two caspase-1-like CARD-only proteins, 
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human inhibitor of CARD (INCA or CARD17) and ICEBERG (or CARD18). Our results reveal 
the surprising finding that INCA caps caspase-1 filament, thereby exerting potent inhibition with 
low nanomolar Ki on caspase-1CARD polymerization in vitro and inflammasome activation in 
cells. While caspase-1CARD uses six complementary surfaces of three types for filament assembly, 
INCA is defective in two of the six interfaces to terminate caspase-1 filament.
As the first line of defense, supramolecular assemblies known as inflammasomes activate 
inflammatory caspases including caspase-1, caspase-11 (mouse), and caspase-4 and -5 
(human) in response to pathogenic invasion and cellular perturbation1,2. Absent in 
melanoma 2 (AIM2)-like receptors (ALRs) and nucleotide-binding domain (NBD) and 
leucine-rich repeat (LRR) containing proteins (NLRs) are inflammasome sensors and 
respond to a variety of pathogen-associated molecular patterns (PAMPs) including cytosolic 
dsDNA and bacterial flagellin, as well as danger-associated molecular patterns (DAMPs) 
such as extracellular ATP, uric acid crystals, and reactive oxygen species3. ALRs and most 
NLRs contain a Pyrin domain (PYD), which recruits apoptosis-associated speck-like protein 
containing a CARD (ASC) through PYD-PYD interactions. ASC also possesses a CARD 
and links the PYD-containing sensor proteins to caspase recruitment, dimerization, and auto-
proteolytic activation through CARD-CARD interactions. Both PYD and CARD belong to 
the death domain (DD) fold superfamily with a conserved six-helical bundle fold4, and are 
shown to interact by nucleated polymerization and filament formation5,6. The NLR family 
proteins NLRBs (also known as NAIPs) do not contain a PYD or CARD and signal through 
the CARD-containing NLRC4 adaptor7,8, which similarly recruits caspase-1 using CARD-
CARD interactions7,9,10. Activated caspases proteolytically process pro-interleukin-1β (pro-
IL-1β) and pro-interleukin-18 (pro-IL-18). The mature cytokines, once released, can initiate 
downstream signaling events leading to the transcription of many pro-inflammatory and 
antiviral genes11. Inflammatory caspase activation can also lead to pyroptotic cell death 
characterized by spillage of cellular contents.
CARD-CARD interactions are essential for the assembly of all inflammasomes. Therefore, 
it is not surprising that a number of CARD-only proteins (COPs) have been identified to 
inhibit inflammasome formation and cytokine maturation12–18. Regulation by COPs is 
proposed to arise because of selective pressure and the need for higher tolerance for 
inflammatory stimuli. Interestingly, rodents and primates all have caspase-1, but COPs are 
only found in higher primates, which suggests that emergence of these genes must originate 
after the human/mouse divergence18. The genes of proposed CARD-only inhibitors, COP1 
(also known as Pseudo-ICE and CARD16), INCA (also known as CARD17), and ICEBERG 
(also known as CARD18), reside near the caspase-1 locus as a result of a series of gene 
duplication events19. New stop codons led to transcripts missing several downstream exons, 
resulting in the translation of CARDs lacking the caspase domain20,21. INCA and ICEBERG 
share 83% and 53% identity to caspase-1 CARD respectively, and may have evolved new 
mechanisms in their functions. Additionally, INCA and caspase-1 are simultaneously 
upregulated by IFN-γ in human monocytic cell lines THP-1 and U937, and ICEBERG, but 
not INCA, is induced by LPS and TNF-α15,16. Therefore, INCA and ICEBERG may play 
distinct roles in different biological settings.
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To fill the knowledge gap on inflammasome activation and its regulation by CARD-CARD 
interactions, we determined the caspase-1CARD filament structure using cryo-electron 
microscopy (cryo-EM), and performed detailed biochemical analyses to understand the 
mechanisms of inhibition by INCA and ICEBERG. Our results provide the first glimpse of a 
CARD complex in the pathway and uncover differential functional effects of ICEBERG and 
INCA. ICEBERG can nucleate caspase-1 filament formation and be incorporated into 
caspase-1 filaments, but fails to effectively inhibit inflammasome activation. Like previously 
suggested, ICEBERG may function by interfering with the interaction of caspase-1 with 
other CARD-containing proteins17. In contrast to ICEBERG, we surprisingly reveal that 
INCA caps caspase-1CARD oligomers to prevent their polymerization, and hence robustly 
inhibits inflammasome assembly in vitro at low nM concentrations. Induced expression of 
INCA in the THP-1 cell line strongly inhibits inflammasome activation. Collectively, our 
study expands the structural knowledge on CARD-CARD interactions during inflammasome 
assembly and regulation.
RESULTS
Cryo-EM reconstruction of the caspase-1CARD filament
We generated a His-MBP-caspase-1CARD-SUMO fusion construct (termed sandwich-
tagged) in order to disrupt caspase-1CARD self-oligomerization during over-expression in E. 
coli (Fig. 1a). The fusion protein was purified by size-exclusion as a monomer, and upon 
removal of the N-terminal His-MBP tag by the Tobacco Etch Virus (TEV) protease, 
spontaneously formed extended singular filaments in cryo-electron micrographs with a few 
hundred nanometers in length (Fig. 1b). An average power spectrum revealed visible layer 
lines that resemble those of the MAVSCARD filament in the RIG-I pathway22, despite the 
lack of the meridional layer line (Fig. 1c, Supplementary Fig. 1a). With the assumption of 
the close similarity, we derived a calculated initial 1-start helical symmetry of −100.23° and 
5.06 Å in rotation and rise per subunit respectively (Fig. 1c). Beginning from a solid cylinder 
model and using iterative helical real-space reconstruction (IHRSR)23, we obtained a final 
volume containing mostly α-helices with refined helical parameters of −100.21° and 5.10 Å 
(Fig. 1d). A homology structure model of caspase-1CARD that we derived from the NMR 
structure of ICEBERG16 could be readily positioned into the density, indicating the 
correctness of the reconstruction (Fig. 1d, Supplementary Fig. 1b–c). The reconstructed 
volume also displayed disordered density outside the caspase-1CARD filament core, which 
may correspond to the flexible C-terminal SUMO-tag (Fig. 1d). The reconstruction was 
estimated to be ~4.8 Å in resolution using both gold standard and model versus map Fourier 
shell correlation plots, with resolved density for some large side chains (Supplementary Fig. 
1b–e), including many at the interface (see below). The final caspase-1CARD model is highly 
similar to the ICEBERG structure (Supplementary Fig. 1f–g).
Structure of the caspase-1CARD filament
Caspase-1CARD filament has an approximate diameter of 8 nm and an inner hole of < 1 nm 
(Fig. 2a). Based on an extended conformation of the ~39 residue linker between the CARD 
and the caspase domain in caspase-1, the closely packed caspase-1CARD in the filament 
would bring the local concentration of the caspase domain to ~3.1 mM. The caspase-1CARD 
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filament forms a left-handed 1-start helical assembly consisting of roughly four subunits per 
turn similar to the Myddosome DD complex and the MAVSCARD filament22,24, using the 
previously defined three types of asymmetric interactions4,25 (Fig. 2b). The type III interface 
harbors interactions in the helical strand direction. The Type I and type II interfaces provide 
interaction between the helical turns (Fig. 2c). The type I interface is the most extensive of 
the three types, with electrostatic complementarity (Fig. 2d). Because of the potential 
inaccuracies in side chain conformations at this resolution, we describe the type Ia patch as 
collectively involving residues in helices α1 and α4 (such as K11, R10, R15, R55, and D52), 
which interact with residues in helix α2 (such as Q31, E28, D27, and N23) (Fig. 2e). In 
contrast, the type II interaction requires an exposed hydrophobic residue, Y82 in the α5-α6 
loop of one subunit, to be inserted into the α2-α3 loop of the adjacent subunit (Fig. 2f). The 
type III interface appears to be the least extensive and may contribute less binding energy 
during filament formation (Fig. 2g).
To validate the importance of these interfacial residues, we generated site-directed mutants 
and compared their properties with wild-type (WT) caspase-1CARD (Fig. 2h–i). We used 
GFP-tagged caspase-1CARD for these experiments because the fusion protein mostly formed 
soluble short filaments, similar to the GFP-AIM2PYD protein26. We first analyzed whether 
the mutations reduced the aggregation tendency of GFP-tagged caspase-1CARD using size-
exclusion chromatography. We then determined whether the mutations decreased the ability 
of GFP-tagged caspase-1CARD to promote filament formation of wild-type monomeric 
caspase-1CARD using fluorescence polarization (FP). For the second experiment, we added a 
C-terminal sortase motif to the His-MBP-caspase-1CARD-SUMO construct used for cryo-
EM. The fusion protein was labeled with the fluorophore TAMRA using recombinant 
sortase A (Fig. 1a)27, and caspase-1CARD polymerization was initiated upon removal of the 
His-MBP tag by the TEV protease. WT GFP-caspase-1CARD, which formed short 
filaments5, robustly nucleated caspase-1CARD polymerization, as indicated by increased FP 
values (Supplementary Fig. 2). The apparent nucleation potency of WT GFP-caspase-1CARD 
was estimated to be ~283.0 ± 1.4 nM (Supplementary Fig. 2).
While GFP-tagged wild-type caspase-1CARD eluted exclusively at the void volume of a 
Superdex 200 gel filtration column, charge-reversal mutants of type Ia (R10E K11E) and Ib 
(D27R E28R) patches abolished caspase-1CARD filament formation, which reflected the 
importance of electrostatic interactions at the type I interface (Fig. 2h). The Y82E mutant at 
the type IIb patch also completely abolished filament formation. In contrast, the charge 
reversal mutant on the type IIa patch, K64E, only impaired, but not abrogated, filament 
formation, suggesting that the type II interface is likely contributed predominately by 
hydrophobic interactions. In the caspase-1CARD polymerization assay, K64E was completely 
incapable of nucleating wild-type caspase-1CARD filament formation (Fig. 2i). Charge 
reversal mutants at the type IIIa patch (K37E or R45E) did not affect either filament 
formation or nucleation. Only a more drastic triple mutant (T49R V50R M51R) at the type 
IIIb surface impaired aggregation and nucleation potency (Fig. 2h–i), consistent with the 
least extensiveness of type III interactions. These results strongly correlated with our 
analysis of the caspase-1CARD cryo-EM structure.
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Caspase-1CARD filament versus other death domain complexes
We compared the caspase-1CARD filament structure to other existing DD fold complexes by 
pairwise structural alignment between isolated dimers of caspase-1CARD and dimers of other 
DD fold complexes. Within the CARD subfamily, MAVSCARD is the only other high-
resolution filament structure recently determined by cryo-EM. Despite having very low 
sequence identity, the helical parameters of MAVSCARD and caspase-1CARD are similar, 
which might have been determined by the relative location of the interfaces (Supplementary 
Fig. 3a–c). We also compared the buried residues in respect to each type of interaction, 
showing that the relative location of these residues indeed correlates very well between the 
two CARDs (Supplementary Fig. 3d). To have a quantitative comparison, we aligned one 
subunit of each interface type and measured how much rotation was required to overlap the 
other subunit (Supplementary Fig. 3e). Between MAVSCARD and caspase-1CARD, rotations 
for type I, II, and III were 10.2°, 8.1°, and 14.1°, respectively. For comparisons of 
caspase-1CARD interactions with those of MyD88DD and RAIDDDD, the rotations were 
respectively 14.1°/8.3°/13.3° and 10.6°/11.3°/21.8°, indicating the more dissimilar 
quaternary structures. Overall, these angular differences were smaller than the relative 
rotations between interactions in the caspase-1CARD filament and the ASCPYD filament 
(14.8°/32.5°/42.3°). This phenomenon may be partially attributed to the helical parameters 
of the oligomeric structures. Caspase-1CARD filament, MAVSCARD filament, and the 
Myddosome are all left-handed 1-start helical assembly, while the ASCPYD filament is a 
right-handed three-start helical assembly5.
INCA displays distinct properties from caspase-1 and ICEBERG
We expressed His-tagged human INCA and ICEBERG, and found that while INCA was 
soluble and monomeric, ICEBERG was largely insoluble (Fig. 3a–b). To investigate the 
biochemical properties of ICEBERG, we fused it to the C-terminus of His-MBP to increase 
its solubility. His-MBP-ICEBERG was soluble but eluted from the void fraction of a 
Superdex 200 size-exclusion column. Removal of the His-MBP tag resulted in long and 
bundled filaments, shown by negative-stain EM (Fig. 3c). The NMR structure of ICEBERG 
solved at pH 3.8, under which the protein is monomeric16, shows a typical CARD structure 
with a six-helix bundle fold that is also highly similar to that of ASCCARD 28. INCA shares 
similar predicted secondary structures and 55% sequence identity to ICEBERG with no gaps 
in the alignment, suggesting that INCA may have a structure highly similar to that of 
ICEBERG (Fig. 3d). Yet, ICEBERG and INCA have contrasting biophysical properties in 
solution. Because sequence comparisons revealed identities of 53% for ICEBERG and 
caspase-1CARD, and 83% for INCA and caspase-1CARD (Fig. 3d), it is therefore the less 
homologous ICEBERG that shares the filament forming ability of caspase-1CARD, while 
INCA is monomeric.
ICEBERG promotes and INCA inhibits caspase-1CARD filaments
We employed the caspase-1CARD polymerization assay to probe the effects of the COPs on 
caspase-1 polymerization. Upon removal of the His-MBP tag by addition of the TEV 
protease, caspase-1CARD-SUMO formed filaments at a negligibly slow rate as shown by the 
minimal change in FP (Fig. 4a). ICEBERG greatly enhanced formation of caspase-1CARD 
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filaments, suggesting that oligomeric ICEBERG provided seeds for polymerization of 
monomeric caspase-1CARD. In contrast, addition of INCA did not have substantial effects on 
caspase-1CARD filament formation at its low basal rate.
In ASC-dependent inflammasomes, it is the CARD of the adaptor ASC that nucleates 
caspase-1CARD polymerization5. To recapitulate this in vitro, we expressed His-GFP fused 
to ASCCARD, the majority of which eluted at the void volume of a Superdex 200 size-
exclusion column (Fig. 4b). Negative-stain EM indicated that the protein formed short His-
GFP-ASCCARD filaments (Fig. 4c). Addition of these ASCCARD filaments at levels well 
below stoichiometry robustly potentiated caspase-1CARD polymerization, with an apparent 
dissociation constant (Kapp) of 108.0 ± 1.4 nM (Fig. 4d). Using fixed His-GFP-ASCCARD 
and caspase-1CARD concentrations, we added sub-stoichiometric amounts of INCA, and 
measured the rates of filament formation. Strikingly, very low concentrations of INCA were 
sufficient to greatly inhibit caspase-1CARD filament formation (Fig. 4e). The apparent 
inhibitory constant (Ki) was measured at 9.4 ± 1.4 nM (Fig. 4e).
To address the question whether ICEBERG could interact with ASCCARD, we designed an 
ASCCARD polymerization assay similar to the caspase-1CARD assay. We expressed and 
purified monomeric His-MBP-ASCCARD-SUMO with a C-terminal sortase motif and 
labeled the protein with the TAMRA fluorophore in vitro using recombinant sortase A. 
Upon addition of the TEV protease, filamentous His-GFP-ASCCARD acted as a nucleator to 
polymerize the labeled, His-MBP removed monomeric ASCCARD-SUMO, indicated by 
increasing FP as a function of time. In contrast, ICEBERG failed to promote ASCCARD 
filament formation (Supplementary Fig. 4a). Moreover, ICEBERG did not inhibit His-GFP-
ASCCARD nucleated ASCCARD polymerization (Supplementary Fig. 4b). Taken together, we 
conclude that there is no apparent interaction between ICEBERG and ASCCARD.
INCA directly inhibits caspase-1 polymerization
The inhibitory effect of INCA with low nM potency in ASCCARD-induced caspase-1CARD 
polymerization was remarkable. To determine whether INCA directly interacts with ASC or 
caspase-1, we co-expressed the proteins in pairs. INCA was cloned into the pDW363 vector 
with an N-terminally fused biotin acceptor peptide (BAP), which allows biotinylation in E. 
coli by the biotin ligase BirA expressed from the same vector29. Biotinylated INCA was first 
co-expressed with His-GFP-ASCCARD. Ni-NTA affinity purification and gel filtration 
chromatography yielded strong Coomassie Blue-stained bands of His-GFP-ASCCARD, but 
no bands of co-purified INCA (Fig. 5a). Streptavidin Western detected a weak band of 
biotinylated INCA co-purified with His-GFP-ASCCARD (Fig. 5a). To clarify if the apparent 
weak interaction has any functional importance, we employed the ASCCARD polymerization 
assay to determine if INCA can inhibit this process. Over-stoichiometric amounts of INCA, 
at up to 10 µM, did not inhibit His-GFP-ASCCARD nucleated ASCCARD filament formation 
(Fig. 5b), suggesting that the ASCCARD–INCA interaction does not exert any functional 
effect.
To determine if INCA interacts with caspase-1CARD, we co-expressed the BAP-INCA fusion 
with His-GFP-caspase-1CARD. Unlike His-GFP-ASCCARD, His-GFP-caspase-1CARD co-
purified with sufficient amounts of INCA to be visible on Coomassie Blue-stained SDS-
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PAGE at 7 and 8 ml (Fig. 5c). Streptavidin Western further confirmed that the bands were 
biotinylated INCA, demonstrating the direct interaction between INCA and caspase-1CARD. 
CARD domains of both ASC and caspase-1 were present in the assays that we employed to 
demonstrate inhibition of caspase-1 polymerization by INCA (Fig. 4e). The assay was thus 
not suitable to determine whether INCA acts on CARD domains of ASC or caspase-1. We 
therefore performed an alternative experiment using His-GFP-caspase-1CARD as the 
nucleator. As aforementioned, His-GFP-caspase-1CARD and His-GFP-ASCCARD were 
similarly potent in nucleating monomeric caspase-1CARD into extended filaments (Fig. 4d, 
Supplementary Fig. 2). Addition of INCA at very low concentrations dramatically inhibited 
His-GFP-caspase-1CARD induced caspase-1CARD polymerization (Fig. 5d). The apparent 
inhibitory constant (Ki) is 4.3 ± 1.4 nM, similar to that obtained in His-GFP-ASCCARD 
induced caspase-1CARD polymerization (Fig. 4e). We also subjected the His-GFP-
caspase-1CARD–biotinylated INCA complex (Fig. 5c) to Streptavidin-gold and Ni-NTA-gold 
labeling and observed that INCA exclusively localized at the tip of caspase-1CARD filaments 
(Fig. 5e–f).
The concentrations of monomeric caspase-1CARD and the pre-formed filamentous nucleators 
used in the polymerization assays were 4.0 µM and 0.1 µM, respectively. The observation 
that INCA inhibits the polymerization reactions with low nM Ki is intriguing. The inhibitory 
constant is about three orders of magnitude lower than the concentration of monomeric 
caspase-1 and about 1/10 to 1/25 of concentrations of the filamentous nucleators. Therefore, 
a plausible explanation might be that INCA only interacts with the filamentous form of 
caspase-1. This interaction can directly occur on the His-GFP-caspase-1CARD filaments. 
When His-GFP-ASCCARD filaments were used, monomeric caspase-1 would polymerize on 
these nucleators. Then His-GFP-ASCCARD–caspase-1CARD complex filaments became able 
to directly interact with INCA. It is conceivable that in both cases, the nucleators were 
capped with INCA, leading to inhibition of polymerization.
Based on the gold labeling experiment (Fig. 5e–f), we quantitatively estimated this strength 
of inhibition by capping. The average length of the His-GFP-caspase-1CARD filaments was 
estimated to be ~150 nm based on the electron micrographs. A similar length estimate was 
derived for His-GFP-ASCCARD filaments (Fig. 4c). Given the observed axial rise per subunit 
of 5.1 Å for the caspase-1CARD filament, the total number of subunit per filament would be 
~30 (Fig. 1d). This suggests that the effective concentration of His-GFP-caspase-1CARD 
nucleator would be ~30-fold lower, about 3 nM, which brings Ki of INCA inhibition in the 
same order of magnitude. Collectively, these data are consistent with the conclusion that 
INCA inhibits caspase-1CARD filament formation by capping small caspase-1CARD 
containing nucleators.
To test this hypothesis, we performed gel filtration analysis to investigate whether His-MBP-
caspase-1CARD-SUMO formed complexes with INCA. At a concentration equivalent to the 
FP assays, caspase-1CARD was incubated with TEV for 90 minutes at room temperature to 
remove the N-terminal His-MBP in the presence or absence of slightly over-stoichiometric 
amount of INCA. As in the experiment shown in Fig. 4a, we expected caspase-1CARD-
SUMO to remain mostly monomeric in the absence of a nucleator. Upon completion of the 
polymerization reaction, the mixtures of MBP-cleaved caspase-1 and INCA were injected to 
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a Superdex 200 column in order to determine if a stable complex was formed. No apparent 
shift in the elution position was observed when the two proteins were run individually or as 
a mixture (Supplementary Fig. 5). This piece of data suggests that INCA does not form a 
stable complex with caspase-1CARD to sequester the monomeric form, but rather caps the 
oligomeric form.
ICEBERG interacts with caspase-1CARD filaments by co-mixing
To test whether ICEBERG directly interacts with caspase-1CARD, we used a similar strategy 
as for INCA and co-expressed biotinylated ICEBERG and His-GFP-caspase-1CARD. Ni-
NTA pulldown showed co-purified biotinylated ICEBERG, though sub-stoichiometric to 
His-GFP-caspase-1CARD, as confirmed by streptavidin Western (Fig. 6a). In size-exclusion 
chromatography, the complex eluted from the void fraction (Fig. 6b). The complex was then 
labeled with Ni-NTA-gold and streptavidin-gold conjugates separately and subjected to 
negative-stain EM analysis to probe the locations of the two proteins in the complex (Fig. 
6c–d). The labeling results showed that both gold conjugates randomly labeled the body of 
the filaments, indicating that ICEBERG co-polymerized with caspase-1CARD into filaments. 
Therefore, despite the fact that both INCA and ICEBERG have been described as CARD-
only proteins, INCA clearly functions through a mechanism different from ICEBERG.
INCA inhibits NLRP3 inflammasome activation in THP-1 cells
Caspase-1 processing and IL-1β secretion are hallmarks of inflammasome activation. We 
assayed both to monitor the effect of inducible expression of ICEBERG or INCA in THP-1 
cells under physiological conditions (Fig. 7). We generated THP-1 cell lines expressing 
either INCA or ICEBERG. Expression of the transgenes was induced by the addition of 
doxycycline (D) for 24h before the experiments. Importantly, doxycycline was withdrawn 
before inflammasome activation because we noticed that expression of any transgene during 
inflammasome activation impaired IL-1β secretion (data not shown). Cells were then treated 
for 3h with LPS and for 45 min with nigericin to induce NLRP3 inflammasome assembly. 
We first analyzed the processing of caspase-1 by an immunoblot, which showed that 
expression of INCA efficiently inhibited the appearance of the processed forms, while 
ICEBERG expression had minimal effects (Fig. 7a). Consistently, secretion of IL-1β in wild-
type THP-1 cells and un-induced cell lines (-D) was comparable as quantified by ELISA 
(Fig. 7b). Expression of INCA efficiently inhibited IL-1β secretion in LPS and nigericin-
treated cells, while expression of EGFP did not impair IL-1β secretion. Expression of 
ICEBERG did not have any substantial effect on IL-1β secretion (Fig. 7b).
Therefore consistent with our in vitro data, the cellular experiments support a model in 
which INCA efficiently perturbs caspase-1 cleavage and activity, presumably due the 
inhibition of caspase-1 polymerization. In contrast, ICEBERG did not seem to inhibit 
NLRP3-dependent inflammasome activation, caspase-1 oligomerization, and caspase-1 
activity. However, the situation in cells is substantially more complex, and it is conceivable 
that ICEBERG levels are insufficient, or that ICEBERG binding to caspase-1CARD is subject 
to regulation by cellular proteins. The question whether ICEBERG is, if at all, a genuine 
inflammasome inhibitor remains to be answered. Even though it physically interacts with 
caspase-1, the exact molecular mechanism of regulation is unclear.
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Structural mechanism of caspase-1 inhibition by INCA
The tendency of death domain fold family proteins to oligomerize into helical oligomers has 
been shown extensively. Examples of DD helical structures include the PIDDosome (DD)25, 
the Myddosome (DD)24, ASC filament (PYD)5 and MAVS filament (CARD)22. We present 
the first CARD filament structure in the inflammasome pathway. For INCA to interact with 
caspase-1, we predict that it must use the similar CARD-CARD interaction surfaces 
observed in the caspase-1CARD filament structure. By this notion, we superimposed a 
predicted INCA monomer model based on the NMR structure of ICEBERG onto the 
caspase-1CARD filament structure, in order to visualize the subtle differences between INCA 
and caspase-1CARD underlying INCA’s inhibitory mechanism (Fig. 8, Supplementary Fig. 
6).
For the type I interaction, INCA has a highly similar type Ia interface, marked by the 
conserved R15 and R55 between caspase-1 and INCA. Strikingly, Asp27 on the caspase-1 
type Ib surface is changed to Gly27 in INCA (Fig. 8a). Such change most likely renders the 
type Ib interface in INCA defective for interaction. According to our mutagenesis studies on 
caspase-1, type Ib mutation (D27R E28R) completely disrupted filament formation and 
resulted in the monomeric form of caspase-1 (Fig. 2h). The type II interface is primarily 
hydrophobic in caspase-1, which relies on Tyr82 for the interaction (Fig. 2f, h). The 
corresponding position in INCA has changed to His82 (Fig. 8b). This will likely render its 
type IIb interface defective for interaction. Type III interface represents the least extensive 
interface and is mostly conserved between INCA and caspase-1CARD (Fig. 8c).
As a result, we propose a model of how INCA inhibits caspase-1CARD via a capping 
mechanism, based on the defective type Ib and IIb interfaces and the intact type Ia, IIa, IIIa, 
and IIIb interfaces (Supplementary Fig. 6). During inflammasome activation by filament 
formation and in the absence of the inhibitory protein INCA, oligomerized ASCCARD 
domains seed caspase-1CARD filaments (Supplementary Fig. 6a). But in the presence of 
INCA, a small caspase-1CARD oligomer can stochastically recruit one or a few subunits of 
INCA through its intact type Ia, IIa, IIIa, and IIIb patches, thereby capping the growing 
caspase-1 filament. Due to the defective type Ib and IIb patches in INCA, the capped 
filament then loses the ability to further recruit inactive, monomeric caspase-1 
(Supplementary Fig. 6b). This capping mechanism explains the high inhibitory potency of 
INCA in blocking caspase-1CARD filament formation in our biochemical assay.
In order to test this model, we generated a charge-reversal mutant, R55E, on the type Ia 
interface of INCA and tested its ability to inhibit GFP-caspase-1 nucleated caspase-1CARD 
filament formation. Type Ia harbors basic residues that are essential for forming the 
electrostatic interactions between neighboring CARDs. Therefore, this mutation in INCA is 
expected to lower its affinity to caspase-1CARD oligomer and thereby abolishes its ability to 
cap the growing caspase-1CARD filament. Predictably, the R55E mutation substantially 
reduced the inhibition potency (Supplementary Fig. 7). When we increased the 
concentrations of R55E in the polymerization assay to drive the inhibition, a Ki of ~1.7 µM 
for R55E was derived, which is ~400 fold higher than that of wild-type INCA. This piece of 
data supports our proposed capping mechanism.
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DISCUSSION
An emerging theme in the field of innate immunity involves the discovery of higher-order 
signalosomes in ligand binding and signal transduction30. The inflammasome assemblies, in 
particular, utilize a nucleated polymerization mechanism5. Through the formation of 
filaments and elaborate aggregates in the cell, component proteins come together for 
efficient activation and signal amplification5,6. This mechanism has also been observed in 
the RIG-I pathway22,31 and the CARMA1–Bcl10–MALT1 pathway32, and can be further 
generalized to related death domain fold containing proteins in other pathways. Extending 
the initial discovery of INCA as an inhibitor of LPS-induced and caspase-1-dependent IL-1β 
secretion1, we investigated its mechanism of inhibition in the context of higher-order 
inflammasome assemblies. We found that INCA is a strikingly efficient inhibitor of 
caspase-1CARD oligomerization, with an apparent inhibitory constant in the nanomolar 
range. We conclude from our biochemical and structural analyses that INCA caps small 
oligomers of caspase-1CARD through CARD-CARD interactions to prevent the further 
recruitment of inactive caspase-1 monomers and the elongation of the CARD filaments 
(Supplementary Fig. 8).
Unlike for INCA, future studies are required to elucidate the functional mechanisms of 
ICEBERG and COP1. ICEBERG oligomerizes and comingles with caspase-1. COP1 has 
two isoforms, a short isoform with CARD only and a longer isoform with an additional ~100 
residues at the C-terminal end. COP1CARD differs from caspase-1CARD in only three 
residues, two of which, H15 and Q37, reside at the predicted filamentous interface (Fig. 3d). 
However, H15 and Q37 are identical in ICEBERG and therefore these differences should not 
affect the interaction of COP1 with caspase-1. Hence, like ICEBERG, COP1 may also 
comingle with caspase-1 filaments. It remains to be determined whether ICEBERG and 
COP1 are bona fide inflammasome inhibitors because our cellular assay failed to show any 
inhibition of NLRP3 inflammasome activation by ICEBERG.
Numerous studies suggest that inflammasomes may represent important therapeutic targets 
against human diseases. For example, genetic evidence in the inflammasome sensor proteins 
NLRP3 (172 known disease variants), Pyrin/MEFV (297 known disease variants), PSTPIP1 
(22 known disease variants) and NLRP12 (32 known disease variants) links inflammasomes 
to hereditary periodic fevers (HPFs), inflammation and autoimmunity. More importantly, 
over-activation of inflammasomes is causal for or associated with highly prevalent 
inflammatory diseases within and outside the immune system1,3,33, including gout, 
rheumatoid arthritis, dermatitis, lung fibrosis34, irritable and inflammatory bowel diseases35, 
neuropathic pain, sepsis, obesity, atherosclerosis36, diabetes37,38, and gastric carcinoma. 
Many of these diseases have limited treatment options, in particular, those that specifically 
address the root of the inflammatory response. The capping mechanism by INCA which we 
discovered here permits interference of inflammasome assembly at a vastly 
substoichiometric ratio, and provides a new potential therapeutic strategy in inhibition of 
inflammasomes, as well as the many other innate immune signaling complexes that utilize 
the death fold domains as the main scaffolding architectures.
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Our studies also made a surprising mechanistic connection to capping proteins that 
dynamically regulate cellular cytoskeletal networks. For instance, the dimeric protein CapZ 
seals the barbered end of actin filaments to prevent their elongation39–41. Human CapZ has 
an apparent dissociation constant of ~3 nM in actin elongation and depolymerization 
assays41. This is comparable to what we report here for INCA in a caspase-1 polymerization 
assay. Fungal metabolites known as cytochalasins, which have the ability to bind actin 
filaments to block their polymerization, offer another example42. The effective 
concentrations of these molecules can range between hundreds of pM to several µM in 
cells43. The apparent equilibrium dissociation constant of cytochalasin D for ADP-actin is 
~1–2 nM44. Collectively, our studies suggest that INCA may very well be the CapZ or 
cytochalasin-equivalent inhibitor of caspase-1 filament elongation, and illustrate a potential 
novel therapeutic mechanism for inflammasome-associated diseases.
ONLINE METHODS
Protein purification
All proteins were expressed in chemically competent BL21(DE3) Escherichia Coli cells by 
overnight induction with 0.4 mM Isopropyl β-D-thiogalactoside (IPTG) at 16 °C. Cells 
expressing hexahistidine (His)-tagged constructs were lysed by sonication in a buffer 
containing 20 mM Sodium HEPES at pH 8.0, 150 mM NaCl, 5 mM imidazole, 10% 
glycerol, and 5 mM β-mercaptoenthanol. Whole cell lysate were centrifuged at 30,000 × g 
for 40 minutes. The supernatant was incubated with Ni-NTA resin (Qiagen) for 1 hour. The 
resin was washed with lysis buffer containing 20 mM imidazole. The target proteins were 
eluted with lysis buffer containing 300 mM imidazole. Subsequent size exclusion 
purification or gel filtration analysis was done on a Superdex 200 10/300 GL column (GE 
Healthcare) in a buffer containing 20 mM Sodium HEPES at pH 8.0, 150 mM NaCl, and 2 
mM DTT. Biotinylated complexes were expressed and purified using the same procedure 
except the addition of 50 µM biotin during IPTG induction. The presence of biotin was 
confirmed by Western blot using streptavidin-conjugated alkaline phosphatase 
(streptavidine-AP, Molecular Probes Cat# S921).
Cryo-EM data collection
Protein sample (3 µl) was applied to glow discharged holey carbon C-flat grids (R1.2/1.3, 
Photochip, CA), blotted for 3 seconds, and plunged into liquid ethane in a FEI Vitrobot 
Mark VI. Frame-packed micrographs were semi-automatically recorded on a FEI Tecnai 
Arctica Cryo-TEM operating at 200 KeV with a K2 summit direct electron detector, under 
super-resolution counting mode with 0.87 Å pixel size. A total of 509 video-mode 
micrographs were collected. The exposure time was 6 seconds and each video stack 
contained 30 sub-frames, with 200 ms exposure per frame. The accumulated dose in each 
stack was 20 electron / Å2.
Cryo-EM reconstruction and structure determination
The helical reconstruction was performed using the iterative helical real space reconstruction 
(IHRSR) method1. Each sub-frame was subjected to gain correction and motion correction 
with SPIDER2, and then summed up to a single image. Defocus range determined by 
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CTFFIND33 was from 1 to 6 µm. Images with defocus higher than 5 µm or still suffering 
from severe astigmatism were excluded. 69,222 segments were cut out from the remaining 
images, with a box size of 200 × 384 pixels and an overlap of 374 pixels (97%). The 
experimental power spectrum was calculated from the original segments that were padded 
into 1024×1024 pixels, with a pixel size 0.87 Å. For the diffraction lines marked as n=2, n=
−1, n=3 and n=−4, the Y coordinates were measured 78, 49, 29 and 20 pixels respectively, 
and the X coordinates were approximately 11, −7, 16 and −22 pixels. By indexing the power 
spectrum, an initial helical symmetry of 5.1 Å in rise and −100.2° in rotation per subunit was 
obtained. Initial reconstruction was carried on with 4 × 4 binned segments, staring from a 
solid cylinder to avoid any model bias. Further refinement was gradually expanded to the 
pixel size of the super-resolution mode. Finally out-of-plane tilt was calculated and imposed 
to these segments until convergence, leading to the final reconstruction. The final density 
started to show helical features. To calculate gold standard Fourier shell correlation (FSC)4, 
we split sorted dataset into two independent halves. Two parallel helical reconstructions 
were executed starting from the solid cylinder model and with the same settings and 
refinement cycles. The resolution was 4.8 Å based on 0.143 cutoff of the gold standard FSC.
Model building and refinement
The nuclear magnetic resonance (NMR) structure of ICEBERG (1DGN)5 was uploaded to 
Swiss-Model server6 to generate an initial caspas-1CARD homology model. The initial model 
was adjusted manually in COOT7 toward the cryo-EM density. A filament model containing 
8 caspase-1CARD subunits was generated in UCSF Chimera8 by applying the helical 
symmetry. The density corresponding to this filament model was masked in CCP49 and 
Fourier transformed to structure factors in the MTZ format using PHENIX10. After rigid 
body phased refinement using PHENIX.refine, the structure was further refined in real space 
using Rosetta11. The model-map cross validation FSC has a value of 0.45 at 4.8 Å 
resolution.
Sortase labeling and fluorescence polarization assay
Constructs for sortase labeling and polymerization assays contain a C-terminal “LPETG” 
polypeptide motif. Calcium-independent sortase and TAMRA conjugated tri-glycine 
nucleophile (GGG-TAMRA) were used12. In short, 30 µM of a freshly purified protein 
substrate with the “LPETG” motif was incubated with 5 µM sortase and 500 µM GGG-
TAMRA overnight at 4°C. The labeled substrate and the excess nucleophile were separated 
by size-exclusion chromatography. Labeled proteins were diluted to desired concentrations 
for fluorescence polarization (FP) assays on a SpectraMax M5e plate reader. Traces of 
polarization values were averaged for triplicate experiments and plotted in Excel.
Calculation of apparent dissociation (Kapp) and inhibitory (Ki) constants
To estimate the apparent dissociation constants between nucleators and polymerizing 
monomers and the inhibitory constant of INCA, we extracted the slopes of the initial linear 
phase of the FP traces in the unit of mP/min and plotted them against the log of the 
concentrations of the added nucleators or INCA. The profiles were fitted in Prism 6.0 for 
Windows (Graphpad Software, La Jolla California USA, www.graphpad.com) using three-
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parameter agonist or antagonist function to determine the concentration of the nucleator or 
the inhibitor at the half maximal effect.
Nano-gold labeling and negative-stain electron microscopy
Gel filtration purified proteins and protein complexes were embedded on a Formvar carbon-
coated EM grid (CFC400-Cu, Electron Microscopy Sciences) and washed 3 times. The grids 
were blotted to remove excess sample and incubated upside-down on a drop containing 
suitable dilution of the Ni-NTA gold reagent (5 nm, Nanoprobes, Inc.) or Streptavidin-gold 
reagent (6 nm, Electron Microscopy Sciences). The grids were washed to remove unbound 
gold and stained with uranyl acetate for negative-stain EM analysis. More detailed protocols 
of these experiments can be found in the methods of our previous paper13.
Generation of INCA and ICEBERG over-expressing THP-1 cell lines
THP-1 human monocyte-like cells (obtained from ATCC) were cultivated in RPMI with 
10% FBS and 50 µM 2-mercaptoethanol. THP-1 cell lines inducibly expressing HA-tagged 
EGFP, ICEBERG, and INCA were generated using lentivirus produced with derivatives of 
pInducer2014 and selected in the presence of 500 µg/ml G418. Monoclonal cell lines were 
obtained by limited dilution in THP-1 medium with 20% FBS. For testing mycoplasma 
contamination, wild-type and derived THP-1 cells were stained with Hoechst 33342 and 
analyzed at high magnification. No punctate DNA staining was observed in the cytosol. 
Alexa Fluor 488 conjugated anti-HA mouse IgG monoclonal antibody (clone 16B12) from 
Life Technologies (Cat#A21287) was used to confirm HA-ICEBERG and HA-INCA 
expression in modified THP-1 cells.
NLRP3 inflammasome activation assay
To quantify IL-1β secretion in response to NLRP3 triggers, THP-1 cell lines were seeded 
into 24-well plates (2.5·105 cells per well) and cultivated in the presence of 50 nM 
Phorbol-12-myristate-13-acetate (PMA, Santa Cruz Biotechnology) for 16h. Cells were then 
grown in full medium with or without 1 µg/ml doxycycline for 24h, sensitized in the 
presence of 200 ng/ml LPS (from Escherichia coli K12, InvivoGen) for 3h, and treated with 
5 µM nigericin in 0.5 ml OptiMEM per well for 45 min. Control samples were incubated 
with medium lacking LPS or nigericin, respectively. Supernatants were harvested, cell debris 
removed by a 10 min spin (1000 × g, 4°C), and samples stored at −20°C. IL-1β levels in a 1: 
200 dilution of the supernatant were determined using the BD OptEIA Human IL-1β ELISA 
Set II (BD Biosciences) according to the manufacturer’s instructions.
Homology modeling of INCA
A monomeric model of INCA was generated using the online Swiss-Model server6 with the 
ICEBERG NMR structure (PDB: 1DGN5) as the template. The INCA model was aligned to 
each subunit of the caspase-1CARD filament cryo-EM structure using the Dali structural 
alignment server to generate an oligomeric INCA model15. Cartoon representations and 
surface electrostatic potential maps were generated in PyMol (http://www.pymol.org/).
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Figure 1. 
Cryo-EM structure determination of the caspase-1CARD filament. (a) Domain organizations 
of pro-caspase-1 and its CARD construct for reconstruction and in vitro fluorescence 
polarization assay. (b) A representative cryo-EM image. (c) Close agreement between 
experimental and simulated power spectra. Selective layer lines are labeled. (d) 
Reconstructed cryo-EM map fitted with caspase-1CARD model in magenta with one subunit 
highlighted in blue. At the right, cryo-EM density is shown in zoom and superimposed with 
a fitted caspase-1CARD molecule.
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Figure 2. 
Structural analysis of the caspase-1CARD filament. (a) Surface representation of the 
caspase-1CARD filament structure. Different subunits are shaded with colors from warm to 
cold. (b) A schematic diagram of the helical filament, with three neighboring subunits 
highlighted in magenta, green, and cyan. (c) Relative orientations of the type Ia, Ib, IIa, IIb, 
IIIa, and IIIb patches. (d) Electrostatic surface renderings of a tetrameric turn showing 
complementary charges. (e–g) The type I (e), II (f), and III (g) interfaces, respectively. Given 
the current resolution, the precise side chain conformations are not implied in the 
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representation. (h) Size-exclusion chromatography analysis showing void and soluble 
fractions of wild-type (WT) and mutant capsase-1CARD. Original images of gels can be 
found in Supplementary Data Set 1. (i) Void fractions of wild-type and mutants were further 
assayed for their potency to nucleate monomeric wild-type caspase-1CARD to form 
filaments. Approximately 140 nM of each nucleator sample and TEV protease were added to 
4 µM of TAMRA-labeled His-MBP-caspase-1CARD-SUMO for polymerization.
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Figure 3. 
ICEBERG is filamentous while INCA is monomeric. (a) Coomassie Blue-stained SDS-
PAGE gel for Ni-NTA affinity purification of E. coil expressed 6×His-tagged ICEBERG and 
INCA. L: whole cell lysate. S: soluble fraction. U: Ni-NTA unbound fraction. E: Ni-NTA 
elution. ICEBERG appeared as aggregate (at ~12kDa) and INCA (at ~15kDa) could bind to 
Ni-NTA beads. (b) Superdex 200 size exclusion chromatography profile of His-tagged 
INCA. INCA eluted at monomeric position. (c) Negative-stain electron micrograph of MBP-
tagged ICEBERG after MBP cleavage. Untagged ICEBERG formed bundled filaments. (d) 
Sequence alignment of ICEBERG, INCA, COP1, ASCCARD, NLRC4CARD, and 
caspase-1CARD. Secondary structures are labeled for ICEBERG and ASCCARD. Regions 
outside of the aligned CARDs are indicated by residue numbers at the end of the alignment. 
Caspase-1 has a caspase domain (CD) ending with residue 404. COP-1 has a C-terminal 
region spanning roughly 100 residues with an unknown fold. NLRC4 has a nucleotide-
binding domain (NBD) followed by leucine-rich repeats (LRR) which ends with residue 
1024.
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Figure 4. 
INCA inhibits ASCCARD nucleated caspase-1CARD filament formation. (a) ICEBERG but 
not INCA nucleated caspase-1CARD filament formation. Average of triplicate experiments 
were plotted. (b) Ni-NTA affinity purification and size exclusion chromatography of His-
GFP-tagged ASCCARD. S: soluble fraction of bacterial lysate. U: Ni-NTA unbound fraction. 
E: Ni-NTA elution. V: void fraction on gel filtration. M: monomer fraction on gel filtration. 
(c) Negative-stain electron micrograph of the His-GFP-ASCCARD void fraction. Scale bar at 
100 nm. (d) Nucleation effect of GFP-tagged ASCCARD at different concentrations on 
caspase-1CARD filament polymerization. Calculation of the apparent dissociation constant 
(Kapp) is shown on the right. (e) Inhibitory effect of INCA at different concentrations on 
His-GFP-ASCCARD nucleated caspase-1CARD filament formation. Calculation of the 
apparent inhibitory constant (Ki) is shown on the right.
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Figure 5. 
INCA preferentially interacts with caspase-1CARD. (a) Co-expression of His-GFP-ASCCARD 
and biotinylated INCA showed no significant interaction between INCA and ASCCARD, as 
indicated by the Western blot. (b) Over-stoichiometric amounts of INCA did not inhibit His-
GFP-ASCCARD nucleated ASCCARD filament formation. Averages of triplicate experiments 
were plotted. (c) Co-expression of His-GFP-caspase-1CARD and biotinylated INCA showed 
interaction between INCA and caspase-1CARD, as confirmed by the PAGE gel. (d) Sub-
stoichiometric amounts of INCA inhibited His-GFP-caspase-1CARD nucleated 
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caspase-1CARD filament formation. Averages of duplicate experiments were plotted. (e–f) 
Negative-stain electron micrographs of the complex (as shown in panel c at 7 ml) between 
His-GFP-caspase-1CARD and biotinylated INCA after streptavidin-gold labeling (e) or Ni-
NTA-gold labeling (f).
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Figure 6. 
ICEBERG interacts with caspase-1CARD by co-mixing. (a) Co-expression of His-GFP-
caspase-1CARD and biotinylated ICEBERG. Streptavidin-AP and anti-6×His-tag Western 
blots were shown to confirm the presence of ICEBERG in complex with His-GFP-
caspase-1CARD after Ni-NTA affinity chromatography. L: Whole cell lysate. S: Soluble 
fraction. U: Ni-NTA unbound. E: Ni-NTA elute. (b) The complex eluted from the void of a 
Superdex 200 column. (c–d) Negative-stain electron micrographs of the complex (as shown 
in panel b at 7 ml) between His-GFP-caspase-1CARD and biotinylated ICEBERG after Ni-
NTA-gold labeling (c) or streptavidin-gold labeling (d).
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Figure 7. 
Inducible expression of ICEBERG and INCA on NLRP3 inflammasome activation in 
modified THP-1 cells treated by LPS and nigericin (Nig). (a) Caspase-1 processing in wild-
type (WT) (unmodified THP-1) and modified THP-1 cells carrying the ICEBERG or INCA 
transgene. (b) ELISA assay for IL-1β secretion for unmodified and modified THP-1 cells 
carrying ICEBERG or INCA transgenes. Doxycycline (D) served to induce the expression of 
transgene. THP-1 cells carrying the EGFP transgene were used as a control. Averaged 
results ± s.e.m. are shown for 3 independent experiments of inflammasome stimulation in 
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the wild-type or stable cell lines. (b) Control experiment showing the inducible expression 
of HA-ICEBERG and HA-INCA in modified THP-1 cell lines as detected by Alexa Fluor 
488 conjugated anti-HA antibody.
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Figure 8. 
Comparison of critical interfacial residues between caspase-1CARD and INCA. Model of an 
INCA monomer was generated using ICEBERG NMR structure as template (PDB: 1DGN). 
It was superimposed on each of the subunit in the caspase-1CARD filament cryo-EM 
structure using the Dali pairwise structural alignment online server. Type I, II, and III 
interfaces of caspase-1CARD and INCA are compared side by side, as shown in (a), (b), and 
(c) respectively. Each of the colors (magenta, cyan, or green) indicates the same subunit 
Lu et al. Page 27
Nat Struct Mol Biol. Author manuscript; available in PMC 2016 October 04.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
across the three interface types. Electrostatic surface representations of the interfaces are 
marked with critical residues for comparison.
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